Research Article

Multiple Patterns of FHIT Gene Homozygous Deletion in Egyptian Breast Cancer Patients

Table 1

Patients clinicopathological features.

Sample no.AgeTumour typeGrade (G)Lymph node status

177IDCG20/5
247IDCG20/9
352IDCG20/12
462IDCG20/8
540ILCNI18/18
6NIAngiosarcomaG33/19
752IDCG26/6
850ILCNI7/9
942IDCG23/12
1035IDCG22/13
1140IDCG25/14
1240ILCNI3/14
1355IDCG2NI
1438IDCG25/8
1550IDCG217/19
1642IDCG20/17
17NIIDCG3NI
1850ILCNI0/13
1958IDCG314/15
2041IDCG24/11
2146IDCG30/19
2242IDCG22/13
2350ILCNI7/7
2444IDCG30/12
2555IDCG25/12
2641IDCG30/24
2734IDCG29/12
2853IDCG20/9
2975IDCG20/7
3055ComedocarcinomaNINI
31NIIDCG2NI
3260IDCG20/16
3350IDCG311/13
3442IDCG36/22
3570IDCG23/17
3645AdenocarcinomaNI1/14
3761IDCG25/18
38NIIDCNI0/10
3958IDCG30/8
4052IDCG21/7
4142IDCG21/15
4255IDCG21/13
4335IDCG215/15
4445IDCG20/12
4540IDCG211/18
4655IDCG26/22
4740IDCG311/20
4835IDCG36/10
4955IDCG24/15
5034IDCG24/11
5150IDCG31/13
5265IDCG25/8
5362IDCG24/15
5442IDCG30/10
5540ILCG1NI
56NIIDCNINI
5750Medullary carcinomaNINI
5835IDCG34/12
5940IDCG36/22
6073Gynecomastia*NINI
6142IDC*G25/12
6244ILCG1NI

IDC: invasive ductal carcinoma, ILC: invasive lobular carcinoma, and NI: no information.
*Male patients.